Abstract
GABA emerges as a trophic signal during rat neocortical development in which it modulates proliferation of neuronal progenitors in the ventricular/subventricular zone (VZ/SVZ) and mediates radial migration of neurons from the VZ/SVZ to the cortical plate/subplate (CP/SP) region. In this study we investigated the role of GABA in the earliest phases of neuronal differentiation in the CP/SP. GABAergic-signaling components emerging during neuronal lineage progression were comprehensively characterized using flow cytometry and immunophenotyping together with physiological indicator dyes. During migration from the VZ/SVZ to the CP/SP, differentiating cortical neurons became predominantly GABAergic, and their dominant GABAA receptor subunit expression pattern changed from α4β1γ1 to α3β3γ2γ3 coincident with an increasing potency of GABA on GABAA receptor-mediated depolarization. GABAA autoreceptor/Cl− channel activity in cultured CP/SP neurons dominated their baseline potential and indirectly their cytosolic Ca2+(Ca2+c) levels via Ca2+ entry through L-type Ca2+channels. Block of this autocrine circuit at the level of GABA synthesis, GABAA receptor activation, intracellular Cl− ion homeostasis, or L-type Ca2+ channels attenuated neurite outgrowth in most GABAergic CP/SP neurons. In the absence of autocrine GABAergic signaling, neuritogenesis could be preserved by depolarizing cells and elevating Ca2+c. These results reveal a morphogenic role for GABA during embryonic neocortical neuron development that involves GABAA autoreceptors and L-type Ca2+ channels.
GABAergic-signaling components emerge and become widespread during the embryonic period of vertebrate CNS development, indicating possible developmental roles for GABA [for a recent monograph, see Barker and Lauder (1998)]. GABA and its synthetic enzymes, the two isoforms of glutamic acid decarboxylase (GAD65 and GAD67), appear throughout the embryonic rat neocortex together with GABAA receptor subunits, which form Cl− ion channels (Lauder et al., 1986;Van Eden et al., 1989; Cobas et al., 1991; Laurie et al., 1992; Poulter et al., 1992, 1993). During the development of embryonic neocortex, GABAergic cells are distributed in the ventricular/subventricular zone (VZ/SVZ) containing proliferating precursors and progenitors, where α4, β1, and γ1 GABAA receptor subunit transcripts and proteins are predominantly expressed (Ma and Barker, 1995, 1998), and in the cortical plate/subplate (CP/SP) region containing differentiating neurons, many of which exhibit α3, β3, and γ2 receptor subunit transcripts and proteins (Maric et al., 1997).
Electrical recordings of cells in embryonic cortical slice preparations have shown that GABA depolarizes cells by activating GABAA receptor/Cl−ion channels (LoTurco et al., 1995). The pharmacological properties of GABAA receptor-coupled Cl− currents recorded in VZ/SVZ neuronal progenitor cells and CP/SP differentiating neurons appear to change, with GABA being more potent in depolarizing the progenitor population (Owens et al., 1999). GABA added to cortical slice preparations differentially modulates neural cell proliferation in the VZ and SVZ (LoTurco et al., 1995; Haydar et al., 2000). In vitro, GABA also acts like a chemoattractant and directs the migration of postmitotic neurons from the VZ/SVZ to the CP/SP via GABAB receptors (Behar et al., 1996, 1998, 2000). In addition, GABA can both stimulate random motility in CP/SP neurons via GABAB receptor-coupled Ca2+ signals and attenuate their own movement via GABAAreceptor/Cl− channels, as neurons become arranged into primitive layers (Behar et al., 1998). Pharmacological activation of GABAAreceptor/Cl− channels expressed by growth cones fractionated from neurons in the developing cortex increases cytosolic Ca2+ levels via voltage-sensitive L-type Ca2+ channels (Fukura et al., 1996), which can lead to Ca2+-dependent phosphorylation of specific proteins (Ohbayashi et al., 1998). These latter results suggest a morphogenic role for GABA related to the physiology of neurite outgrowth among embryonic cortical neurons.
In this study, we investigated the cellular distributions of GABAergic-signaling components emerging at the end of neurogenesis in the embryonic rat neocortex and examined the functional role of GABA on neurite outgrowth after radial migration of neurons into the CP/SP. GABAergic-signaling components, including the expression of GAD65, GAD67, GABA, GABAA, and GABAB receptor subunits, and GABAergic signals at GABAAreceptor/Cl− channels emerged in the VZ at the earliest stages of neuronal lineage progression. In CP/SP neurons, autocrine GABAergic signals dominated their baseline membrane potential and cytosolic Ca2+ levels. This autocrine activity was critical to neurite outgrowth, because interruption of each component in the circuit markedly attenuated process formation and/or regeneration without altering cell survival.
Parts of this paper have been published previously (Maric et al., 1998a).
MATERIALS AND METHODS
Cell preparation
Experiments were performed on embryos recovered from timed-pregnant Sprague Dawley rats (Taconic, Germantown, NY) during the last half of gestation. The embryonic age was determined by comparing the crown–rump lengths of embryos with previously published values (Hebel and Stromberg, 1986). The day of conception was taken as embryonic day 1 (E1). All of the research was performed in compliance with the Animal Welfare Act and the Public Health Service policy on Humane Care and Use of Laboratory Animals and was approved by the National Institute of Neurological Disorders and Stroke Animal Care and Use Committee.
Most of the study was focused on developing neocortical cells at E19. To obtain access to neuronal subpopulations before and after radial migration, 350-μm-thick coronal sections of the brain at the level of the midposterior neocortex, which corresponded to coronal plates 9–12 (Altman and Bayer, 1995), were microdissected along the incipient white matter into a CP/SP region and a VZ/SVZ zone, and the tissues were then optimally dissociated into single-cell suspensions, as described previously (Maric et al., 1997, 2000b). The cells were subsequently washed and finally resuspended at a density of 2 × 106 cells/ml in a normal physiological medium (NPM) consisting of (in mm): 145 NaCl, 5 KC1, 1.8 CaCl2, 0.8 MgCl2, 10 glucose, and 10 HEPES, pH 7.3 (osmolarity, 290 mOsm). During the initial cell preparation and under some experimental conditions, NPM was supplemented with 1 mg/ml bovine serum albumin (NPM/BSA), which was obtained from Sigma (St. Louis, MO).
Immunostaining protocols
Immunolabeling of surface and cytoplasmic epitopes was performed in Dulbecco's PBS (Quality Biologicals, Gaithersburg, MD) supplemented with 1 mg/ml BSA (PBS/BSA). Unless stated otherwise, PBS/BSA was also used as a diluent for the preparation of working stocks of all primary and secondary antibodies. All immunoreactions were performed at room temperature (RT).
Immunofluorescent labeling of surface epitopes. To discriminate among the developing cortical cells progressing along neuronal and glial cell lineages, we used a mouse monoclonal class IgM anti-A2B5 antibody (Boehringer Mannheim, Indianapolis, IN) and a mixture of tetanus toxin fragment C (TnTx; Boehringer Mannheim) and a mouse monoclonal class IgG2b anti-TnTx antibody (obtained from Dr. William Habig, Food and Drug Administration, Bethesda, MD), as described previously (Maric et al., 1999a, 2000b). Briefly, acutely dissociated cells in suspension were double-immunoreacted with 1 μg/ml anti-A2B5 and TnTx/anti-TnTx for 30 min and then washed in NPM, and the primary immunoreactions were visualized by immunostaining with 10 μg/ml phycoerythrin (PE)-conjugated goat anti-mouse IgM and PE/CY5-conjugated goat anti-mouse IgG2b antibodies (Caltag, South San Francisco, CA) for an additional 30 min.
Immunofluorescent labeling of cytoplasmic epitopes. To immunotype TnTx/A2B5-labeled populations further, we performed triple-staining protocols using antibodies specific for different components of the GABAergic-signaling pathway. These included rabbit polyclonal anti-GABA (Sigma) and two anti-GAD antibodies specific for GAD65 and GAD67 isoforms (obtained from Dr. David L. Martin, State University of New York, Albany, NY). In addition, the expression of 13 GABAA and 2 GABAB receptor subunits was investigated in the TnTx/A2B5-labeled subpopulations using specific antibodies generated against appropriate synthetic peptides or fusion proteins (sequences of targeted amino acid residues are depicted in parentheses). GABAA receptor antibodies included guinea pig polyclonals specific for α2 (1–9) and α3 (1–15) subunits (obtained from Dr. Jean-Marc Fritschy, University of Zurich, Zurich, Switzerland) and rabbit polyclonals specific for α1 (1–9), α4 (379–421), α5 (2–10), α6 (429–434), β1 (350–404), β2 (351–405), β3 (345–408), γ1 (324–366), γ2 (319–366), γ3 (322–372), and δ (1–44) subunits (obtained from Dr. Werner Sieghart, University Clinic for Psychiatry, Vienna, Austria); GABAB receptor antibodies included guinea pig polyclonals specific for R1 (both R1a and R1b isoforms) and R2 subunits (Chemicon, Temecula, CA). The characterization and specificity of the aforementioned antibodies have been described elsewhere (Benke et al., 1991, 1997; Buchstaller et al., 1991; Marksitzer et al., 1993; Martin and Rimvall, 1993; Mertens et al., 1993; Rimvall et al., 1993; Mossier et al., 1994; Todd et al., 1996; Sperk et al., 1997; Jones et al., 1998; Kaupmann et al., 1998; White et al., 1998; Durkin et al., 1999; Martin et al., 1999; Yung et al., 1999; Calver et al., 2000;Princivalle et al., 2000).
In short, the staining protocol was as follows. The cells were first surface labeled with anti-A2B5-PE and anti-TnTx-PE/CY5, then fixed in 4% paraformaldehyde (PF) for 30 min, washed three times in PBS/BSA, and immunolabeled with appropriate dilutions of anti-GABA, anti-GAD65, anti-GAD67, or one of the aforementioned GABAA or GABAB receptor subunit antibodies for 1 hr. The primary immunoreactions were visualized after a 30 min incubation with the appropriate fluorescein isothiocyanate (FITC)-conjugated donkey anti-rabbit or donkey anti-guinea pig IgG secondary antibodies (5–10 μg/ml; Jackson ImmunoResearch, West Grove, PA). Control immunoreactions, in which the primary and/or the secondary antibodies were omitted during the staining protocol, were also performed. Nonspecific staining of these antibodies was minimized by a 30 min blocking step in PBS containing 10% (v/v) normal rat serum and 10% (v/v) normal donkey serum (Jackson ImmunoResearch). The same solution was also used as a diluent during the incubation steps with primary and secondary antibodies.
Flow-cytometic detection of fluorescently labeled epitopes.Surface and cytoplasmic immunoreactions among TnTx/A2B5-labeled subpopulations in suspension were quantified in 100,000-cell samples using the FACSTAR+ flow cytometer (Becton Dickinson, Mountain View, CA), as detailed previously (Maric et al., 1999a, 2000b). Briefly, the FITC, PE, and PE/CY5 fluorescence signals were excited by an argon ion laser (model 2016; Spectra-Physics, Mountain View, CA) tuned to obtain 500 mW power at 488 nm, and the resulting fluorescence emissions were collected using bandpass filters set at 530 ± 30, 575 ± 25, and 670 ± 20 nm, respectively. Cell Quest Analysis software (Becton Dickinson) was used to quantify the fluorescence signal intensities among the immunolabeled subpopulations.
EM immunocytochemistry. The distribution of GABA immunoreactivity at the subcellular level was examined using an immunogold labeling protocol in conjunction with transmission electron microscopy. Acutely prepared CP/SP neurons were allowed to adhere on eight-well plastic chamber slides (Nunc, Naperville, IL) and were then cultured for 24 hr in Neurobasal medium supplemented with B27 additives (Life Technologies, Gaithersburg, MD). The cells were then fixed in 4% PF (EM grade; EMS, Ft. Washington, PA) for 30 min, washed three times in PBS, permeabilized with PBS/BSA/0.1% saponin (Sigma), which also served as the diluent for primary and secondary antibodies, and immunoreacted with 2 μg/ml rabbit anti-GABA antibody for 1 hr. The primary immunoreaction was visualized with 5 μg/ml goat anti-rabbit secondary antibody (Fab′ fragment) conjugated to a 1.4 nm gold particle (Nanoprobes, Stonybrook, NY), followed by a silver enhancement and EM processing steps as detailed previously (Tanner et al., 1996). Control cells excluded one of the following: (1) primary antibody, (2) secondary antibody, or (3) primary and secondary antibody.
Immunohistochemistry. In some experiments, E19 rat brains were fixed in 4% PF for 4 hr, cryoprotected in 30% sucrose for 3–5 d at 4°C, and frozen in liquid nitrogen-cooled isopentane (Fisher Scientific, Fair Lawn, NJ). Twenty-micrometer-thick coronal sections were cut using a Jung Frigocut cryostat (model 2800E; Leica, Nussloch, Germany) and then dried at RT for 1 hr and immunoreacted with appropriate dilutions of the aforementioned GABAAor GABAB receptor subunit-specific antibodies overnight. For immunohistochemistry, all antibodies were diluted in PBS containing 10% (v/v) normal rat serum and 10% (v/v) normal donkey serum, as described above, to prevent nonspecific binding. In control slides, the primary antibodies were substituted with diluent only. The sections were then incubated for 1 hr with biotinylated donkey antibodies against appropriate species (Jackson ImmunoResearch), which served as secondary immunoreagents. Finally, the cells were reacted for 1 hr with streptavidin-conjugated horseradish peroxidase (Jackson ImmunoResearch) and developed in 3-amino-9-ethyl carbazole (AEC) substrate (Sigma; 25 mg of AEC in 100 ml of acetate buffer) with 0.01% H2O2 for 10–15 min at RT. The slides were then coverslipped, and the sections were imaged under a transmission light microscope using the NIH Image software (developed at the National Institutes of Health and available on the Internet at http://rsb.info.nih.gov/nih-image/) on the Macintosh workstation.
Flow-cytometric recordings of calcium and potentiometric signals
E19 cells immunolabeled with TnTx-PE/CY5 and A2B5-PE were stained with either potentiometric or Ca2+indicator dyes to record their membrane potential or cytosolic Ca2+(Ca2+c) levels under resting baseline conditions in NPM and in response to various agonists, as described previously (Maric et al., 2000b). Briefly, to record membrane potential (MP), immunolabeled cells were resuspended at a density of 2 × 106 cells/ml and stained with 200 nm bis-(1,3-dibutylbarbituric acid)trimethine oxonol (Molecular Probes, Eugene, OR) for 10 min at RT to allow complete equilibration of the negatively charged dye with cell plasma membranes before recording MP values. Alternatively, the immunolabeled cells were loaded with 100 nm fluo-3 AM, a Ca2+ indicator dye (Molecular Probes), for 20 min at RT and then washed to remove unincorporated dye and resuspended in NPM for 30 min to permit deesterification before recording Ca2+c levels. Both oxonol and fluo-3 were excited at 488 nm, and their fluorescence emissions were detected with a bandpass filter set at 525 ± 15 nm. In triple-staining experiments, the spectral overlap of fluo-3 or oxonol fluorescence emissions into the PE detection window and of PE fluorescence signals into the PE/CY5 detection window was electronically compensated at the preamplifier stage.
Modal values in the oxonol and fluo-3 fluorescence signal distributions were calibrated in terms of MP or [Ca2+]c using previously established protocols (Maric et al., 1998b,c, 1999a). Typically, resting MP and Ca2+c levels were randomly recorded from 100,000 TnTx/A2B5-immunoidentified cells at the rate of ∼2000 cells/sec. The modal (approximate mean in symmetrically distributed signals) MP or Ca2+c values expressed by different subpopulations were quantified by gating electronically on TnTx and/or A2B5 immunofluorescence signals. This combined surface-labeling-and-indicator-dye-recording strategy allowed us to profile the physiological properties of virtually all neocortical cell phenotypes (i.e., neural precursors, neuronal and neuroglial progenitors, and differentiating neurons) in suspension in a rapid and statistically complete manner (Maric et al., 2000b). TnTx/A2B5 labeling itself did not trigger detectable changes in either baseline membrane potential or Ca2+c (data not shown).
Dual video microscopic imaging of calcium and potentiometric signals
Dual-indicator dye digital video microscopic imaging of Ca2+c and membrane potential was performed on fields of 20–30 isolated cells cultured from the CP/SP, as detailed elsewhere (Maric et al., 2000b). Briefly, the cells were plated at a density of 2 × 104 cells/cm2on poly-d-lysine-coated coverslips, which were photoetched with an α-numeric grid (Bellco Glass, Inc., Vineland, NJ), preglued to 35 mm tissue culture dishes (MatTek Corporation, Ashland, MA), and cultured for 24–48 hr in Neurobasal/B27 medium. At the end of culture, the cells were loaded with 2 μm fura-2 AM (Molecular Probes) for 1 hr at 37° C, washed in NPM, and stained for 10 min at RT with 500 nm oxonol. Because oxonol equilibrates dynamically according to the cell membrane potential, the dye was included in all recording solutions, which were delivered to the 150 μl recording chamber using gravity-driven perfusion at ∼2 ml/min.
The cells were imaged using the Attofluor RatioVision workstation (Atto Instruments, Rockville, MD) equipped with an Axiovert 135 inverted microscope (Carl Zeiss, Thornwood, NY) and an intensified ICCD camera (Atto Instruments). The indicator dyes were sequentially excited at 1 sec intervals with a 100 W mercury arc lamp filtered at 488 ± 5 nm for oxonol and at 334 ± 5 and 380 ± 5 nm for fura-2. Fluorescence emissions were acquired through a 510 nm dichroic mirror and a 520 nm long-pass filter set (Chroma Technology Corporation, Brattleboro, VT). Regions of interest (ROIs) were drawn electronically around individual cell bodies, and indicator dye fluorescence signals of each ROI were digitized with a Matrox image processing board and then plotted as line graphs using Attograph for Windows analysis software (Atto Instruments). Oxonol and fura-2 fluorescence signal distributions were calibrated in terms of MP or [Ca2+]c using previously established protocols (Maric et al., 1998c, 2000b).
After imaging, the field of recorded cells was photographed with a 35 mm camera using phase-contrast optics to reveal their location with respect to the underlying alphanumeric grid. The cells were then washed in NPM to remove the oxonol dye and then immunostained with anti-A2B5-PE, anti-TnTx-PE/CY5, and anti-GABA-FITC, as described above. In this way, the physiological properties of individual cells at membrane and cytoplasmic levels could be recorded simultaneously and then correlated with their differentiation state.
Electrophysiology
Before recording, the Neurobasal culture medium was replaced with Tyrode's solution containing (in mm): 145 NaCl, 5.4 KCl, 1.8 CaCl2, 0.8 MgCl2, 10 glucose, and 10 HEPES-NaOH, pH 7.4 (310 mOsm). Standard patch-clamp recordings (Hamill et al., 1981) were made with pipettes pulled in three stages from 1.5-mm-outer diameter glass capillary tubes (WPI, Sarasota, FL) with a computer-controlled pipette puller (BB-CH-PC; Mecanex; Geneva, Switzerland). These pipettes had a resistance of 3–5 MΩ when filled with internal solution composed of (in mm): 145 CsCl, 2 MgCl2, 0.1 CaCl2, 1.1 EGTA, 5 HEPES, 5 ATP (potassium salt), and 5 phosphocreatine, pH 7.2 (290 mOsm). Whole-cell currents were recorded with an L/M EPC-7 patch-clamp amplifier (Medical Systems Corporation, Greenvale, NY) at a gain of 5 mV/pA for whole-cell current and 100 mV/pA for single-channel current. Series resistance was compensated for >70%. Current signals were stored on videocassettes via a videocassette recorder and a VR-100 digital recorder (Instrutech) for later off-line digitization with Digidata 1200 (Axon Instruments, Foster City, CA) and analysis with Pclamp V6.0 (Axon Instruments) on a Pentium-based personal computer. All recordings were performed at RT (22–25°C) on a Nikon inverted microscope. For superfusing the cells, we used a perfusion system composed of a locally made controller and miniature electric solenoid valves (The Lee Company, Essex, CT) that allows fast switching (<200 msec complete solution exchange time) among different solutions (Liu et al., 1999). The perfusion rate (∼0.3–0.5 ml/min) was controlled by the air pressure applied to the solution reservoirs.
Pharmacology
We used both flow-cytometric and dual-imaging strategies to examine the emergence and characterize the properties of GABAergic-signaling components in entire populations and in single cells, respectively. Pharmacological experiments were performed by exposing the cells to GABA, muscimol, bicuculline (BIC), picrotoxin (PIC), baclofen, and/or saclofen (SAC) to reveal expression of GABAA/Cl−channels and GABAB/Ca2+channels. The cells were also exposed to furosemide, which blocks Cl− ion transport into cells, 3-mercaptopropionic acid (3-MPA), which blocks GAD activity, and nitrendipine (NTDP), which blocks voltage-dependent L-type Ca2+ channels. In some experiments, the cells were exposed to ionomycin, a Ca2+ ionophore, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), and/or 2-amino-5-phosphonovaleric acid (APV), respective antagonists at ionotropic glutamate receptors of the AMPA/kainate or NMDA subtype, atropine and/or suramin, respective antagonists of muscarinic acetylcholine receptors and P2 purinoreceptors, and tetrodotoxin (TTX), a blocker of voltage-sensitive Na+channels. Muscimol and APV were obtained from Research Biochemicals (Natick, MA). All other reagents were purchased from Sigma. Some recordings were performed in NPM/BSA, which effectively reduced the effects of endogenous GABA signaling (see Results) and adequately stabilized the baseline cell properties during the experimental period. Otherwise, the recordings were performed in NPM. All experiments were conducted at RT.
RESULTS
GABAA receptor subunit expressions change with neuronal lineage development
We identified subpopulations of proliferating neural precursors, neuronal and neuroglial progenitors, and differentiating neurons in the embryonic rat neocortex using recently developed surface-labeling techniques (Maric et al., 2000b). Cells were identified on the basis of their surface expression of neuron-specific tetanus toxin (TnTx) and progenitor-selective A2B5 markers (Fig.1). Microdissection of the neocortex into VZ/SVZ and CP/SP regions further resolved the TnTx/A2B5-immunoidentified cells according to their anatomical location. Four cell phenotypes composed the VZ/SVZ (see Maric et al., 2000b): neural precursors not labeled with TnTx or A2B5 [TnTx−A2B5−, double-negative (DN)], neuroglial progenitors labeled only with A2B5 [single-positive for A2B5 (SP-A2B5)], and two subpopulations of neuronal progenitors, one that labeled with TnTx at low intensity (SP-TnTxlo) and the other that stained double-positive for both TnTx at low intensity and A2B5 (DP-TnTxlo). In contrast, two subpopulations of differentiating neurons predominated in the CP/SP region: neurons that were labeled with TnTx at high intensity (SP-TnTxhi) and neurons that were double-positive for both TnTx at high intensity and A2B5 (DP-TnTxhi).
After microdissection and surface phenotyping with TnTx and A2B5, the cells were fixed and immunostained for 13 GABAAreceptor (α1–6, β1–3, γ1–3, and δ) and 2 GABAB receptor (R1 and R2) subunits, and the resulting immunoreactions were quantified by flow cytometry. The data revealed changing patterns of GABAA receptor subunit expressions among the TnTx/A2B5-immunoidentified subpopulations, which were coincident with neuronal maturation (Fig.1). Approximately half of the TnTx−A2B5−neural precursor cells expressed immunodetectable α4, β1, γ1, or γ3 GABAA receptor subunits and both GABAB receptor R1 and R2 subunits. The expression of α4, β1, or γ1 subunits became quite widespread in >75% of SP-TnTxlo neuronal progenitors in the VZ/SVZ, 30–50% of which also exhibited α3, β2, γ2, γ3, or δ subunit immunoreactivity. The trio of α4, β1, and γ1 GABAA receptor subunits was the only one detected at significant levels in 20–40% of DP-TnTxlo neurons. However, as DP-TnTxlo progenitors became DP-TnTxhi differentiating neurons, after migration to the CP/SP region, the expression of α4, β1, or γ1 GABAA receptor subunits became significantly reduced, whereas the expression of α3, β3, γ2, or γ3 GABAA receptor subunits became predominant in most (55–75%) of these cells. The trio of α4, β1, and γ1 subunit expression was likewise quite reduced among SP-TnTxhi neurons in the CP/SP region compared with SP-TnTxlo neuronal progenitors in the VZ/SVZ. For example, α4 decreased from ∼90 to ∼55% in relative abundance, β1 decreased from ∼85 to ∼25%, and γ1 decreased from ∼75 to ∼20%. In addition, δ GABAA receptor subunit expression decreased from ∼50% in SP-TnTxlo neuronal progenitors to ∼20% in SP-TnTxhi neurons. Like DP-TnTxhi neurons, the great majority of SP-TnTxhi neurons (85–95%) were α3+, β3+, γ2+, or γ3+. Both GABABreceptor subunits were expressed by ∼50% of the SP-TnTxhi neurons. Neither α1 nor α6 subunits were immunodetectable in any subpopulation, whereas α5 subunit was expressed in a minor proportion (≤20%) of each TnTx+ subpopulation. SP-A2B5 neuroglial progenitors in the VZ/SVZ did not express GABAAand GABAB receptors.
These results demonstrate changing patterns of GABAA and relatively constant expressions of GABAB receptor subunit immunoreactivities during neuronal lineage progression. The expression of α4, β1, γ1, and δ GABAA receptor subunits decreased as neurons migrated from the VZ/SVZ to the CP/SP, where α3, β3, γ2, and γ3 GABAA receptor subunits predominated.
The changing GABAA receptor subunit expressions quantified during neuronal lineage progression led us to identify their distributions in the intact anatomy of the neocortex at E19. The anatomical distributions corresponded well to the results derived from quantitative flow-cytometric analyses of microdissected subpopulations. For example, subunits dominant among CP/SP dissociates (e.g., α3, β3, γ2) were readily detected in the CP/SP region with intense immunoreaction signals distributed among both cell bodies and radiating processes (Fig. 2). However, there was little, if any, detectable expression of these subunits in the VZ/SVZ. Subunits dominant among VZ/SVZ dissociates (e.g., α4, β1, γ1) were found primarily but not exclusively in the VZ (e.g., α4). The distributions of these GABAA receptor subunit proteins parallel those of the corresponding transcripts, as reported previously (Poulter et al., 1993; Ma and Barker, 1995). Together, these results identify the different anatomical distributions of cells with evolving GABAA receptor subunit expression patterns, which could form functional GABAAreceptor/Cl− channels.
In contrast to the more restricted distributions of the aforementioned GABAA receptor subunits, the anatomical distribution of GABAB receptor R1 and R2 subunits was relatively widespread throughout the developing neocortex at E19 (Fig. 2), with the immunoreactions for each subunit detected in the VZ/SVZ and CP/SP as well as on putative migrating neurons in the IZ. These findings indicate that these GABAB receptor subunits are expressed in both early and late stages of cortical neuron development. In addition, the immunohistochemical distribution of each GABAB receptor subunit in the E19 neocortex appeared to be quite similar, suggesting that these receptor subunits are coexpressed and probably constitute a heteromeric complex, which has been implicated in composing functional GABABreceptors in the CNS (Jones et al., 1998; Bowery and Enna, 2000; Couve et al., 2000). Functional GABAB receptors have been shown previously to mediate cortical neuronal migration from the VZ/SVZ to the CP/SP in rat neocortex over E17–E19 (Behar et al., 1996,1998, 2000).
GABAergic-signaling components emerge in parallel with GABA receptors
We examined the cellular distributions of other putative GABAergic-signaling components emerging during neuronal lineage progression including the expression of two GABA-synthesizing enzymes (GAD65 and GAD67) and GABA (Fig. 3). Approximately 55–60% of the DN precursors were either GAD65+ or GAD67+ (Fig.3A2,B2), whereas <10% of SP-A2B5 neuroglial progenitors were immunopositive for either GAD (Fig. 3A1,A2,B1,B2). Approximately 75–90% of the SP-TnTxloneuronal progenitors were either GAD65+ or GAD67+, making it likely that both enzymes were coexpressed in these cells. A minority of DP-TnTxlo progenitors and DP-TnTxhi neurons were GAD65+ (∼30 and ∼35%, respectively) or GAD67+ (∼18 and ∼15%, respectively), whereas the majority of SP-TnTxhi neurons were either GAD65+ (∼80%) or GAD67+ (∼65%). GABA was primarily confined to neural precursors (∼55%), SP-TnTxlo neuronal progenitors (∼75%), and differentiating SP-TnTxhi neurons (∼95%), while being almost completely absent among SP-A2B5 cells (Fig. 3C1,C2). These results indicate that all of the components necessary to generate autocrine and paracrine GABAergic signals at GABA receptors are expressed during neuronal lineage progression, particularly in SP-TnTx neurons (see below).
GABA release is dependent on Ca2+ entry via L-type Ca2+ channels
The emergence of GABAergic neurons in the developing neocortex prompted us to investigate the possible mechanisms of GABA release from these cells. By using cell dissociation and TnTx/A2B5-labeling in conjunction with forward angle light scatter characteristics, a flow-cytometric property related to particle size (Fig.4A), we examined the GABA immunoreactivity from cellular and subcellular compartments after treatment with different pharmacological conditions. Subcellular elements expressed the same pattern of TnTx and A2B5 labeling that was expressed by cell bodies with a significant percentage exhibiting the same high level of TnTx-labeling intensity found with SP-TnTxhi neurons (Fig.4B), suggesting that these elements represented sheared-off processes or growth cones from these cells. These data are supported by previous observations, which showed that TnTx labels the surface of embryonic cortical neurons quite uniformly (Maric et al., 2000b) and that TnTx+GABA+growth cones are readily detected in short-term cultures of embryonic neurons (Vautrin et al., 2000). To test GABA release, TnTx/A2B5-labeled neocortical dissociates were treated for 15 min with increasing [K+]o to depolarize cells or ionomycin to elevate intracellular Ca2+. The cells and subcellular elements were then spun down, fixed in 4% PF, and processed for GABA immunostaining, and the resulting immunoreactivity was quantified by flow cytometry. Under control conditions in NPM, ∼90% of both SP-TnTxhi cell bodies and subcellular elements (putative growth cones) were GABA immunoreactive (Fig.4C,D). The percentages of GABA-immunopositive cells and growth cones decreased in parallel when K+o was elevated or ionomycin was added in NPM during the 15 min incubation (Fig.4C,D). Exposure to ionomycin led to an ∼90% decrease in GABA-immunopositive cell bodies and growth cones, demonstrating that most of the immunodetectable GABA was labile (Fig. 4C,D). Furthermore, the released GABA was not adherent to or taken up by other cells because decreases were also detected in the percentages of GABA+ cell bodies at earlier stages of lineage progression, whereas GABA− cells did not become GABA+ (D. Maric and J. L. Barker, unpublished observations). GABA+SP-TnTxlo neuronal progenitors were less sensitive to K+o-induced release, whereas GABA+TnTx−A2B5−neural precursors were the least sensitive and did not respond to 20 mm KCl (data not shown). However, ionomycin released ∼90% of the immunodetectable GABA in these subpopulations, indicating that the GABA emergent in the earlier stages of lineage progression was also labile.
The Ca2+ dependency of evoked GABA release was evaluated by resuspending cells in Ca2+o-free saline and then exposing them to elevated K+o or ionomycin. Resuspension in Ca2+o-free saline did not affect the percentages of GABA+SP-TnTxhi cell bodies and growth cones but completely eliminated the changes induced by elevated K+o (Fig.4E,F) and ionomycin (data not shown). These results demonstrate that Ca2+ entry is necessary to release immunodetectable GABA and that intracellular Ca2+ release, which occurs in these cells in Ca2+-free saline when exposed to ionomycin (Maric et al., 2000a), is not effective.
We also studied the possible role of voltage-dependent L-type Ca2+ channels in Ca2+-dependent GABA release, because these channels become functionally expressed during neuronal lineage progression (Maric et al., 2000a). Nitrendipine, which blocks L-type Ca2+ channels, antagonized the GABA release by elevated K+oin both SP-TnTxhi cell bodies and growth cones (Fig. 4E,F), thus identifying voltage-dependent L-type Ca2+ channels as the primary pathway for Ca2+ entry triggering GABA release. Collectively, these results demonstrate that most of the GABA in cell bodies and growth cones of differentiating cortical neurons is labile and can be released via Ca2+ entry through L-type Ca2+ channels.
Functional responses to GABA increase during neuronal differentiation
To investigate the appearance and distribution of functional GABAergic signals during cortical cell development, CP/SP and VZ/SVZ dissociates were immunolabeled with TnTx/A2B5 and stained with potentiometric or calcium-sensitive physiological indicator dyes, before pharmacological experiments targeting GABAA and GABABreceptors were performed. Because differentiating neocortical neurons became progressively GABAergic (Fig. 3) and endogenous GABA signaling increasingly contributed to their baseline properties (see Figs. 6-9), we have empirically supplemented the NPM with BSA, which effectively reduced the contribution of endogenous GABA signaling (see Fig.9A), before testing the effects of exogenously applied GABA or GABA-mimetic agonists or antagonists. As expected from the distribution of GABA receptor subunits among phenotyped subpopulations (Fig. 1), both membrane potential and Ca2+c responses to exogenous GABA were primarily confined to cells undergoing neuronal differentiation (Fig. 5). GABA depolarized or elevated Ca2+c in only a fraction (10–15%) of the TnTx−A2B5−neural precursors and SP-A2B5 neuroglial progenitors from the VZ/SVZ (Fig. 5A1,A2,B1,B2). GABA responses increased in DP-TnTxlo neuronal progenitors, 25% of which depolarized (Fig. 5A2), but none elevated Ca2+c (Fig.5B2). In contrast, ∼50% of the SP-TnTxlo neuronal progenitors depolarized (Fig. 5A2) and ∼25% elevated Ca2+c (Fig.5B2) after exposure to GABA. Similarly, GABA depolarized ∼60% of the DP-TnTxhi neurons (Fig.5A2), while elevating Ca2+c in only ∼20% (Fig. 5B2). The most responsive population was detected among SP-TnTxhi neurons from the CP/SP, ∼90% of which were depolarized by GABA (Fig. 5A1,A2) and ∼55% of which responded with elevated Ca2+c (Fig.5B1,B2).
Virtually all of the depolarizing responses to GABA were mimicked by the GABAA receptor agonist muscimol and blocked by either bicuculline or picrotoxin (data not shown; but see Figs.6-9), indicating a direct involvement of GABAAreceptor/Cl− channels in the phenomenology. Elevation in Ca2+c levels induced by GABA was for the most part antagonized by bicuculline, picrotoxin, and nitrendipine (data not shown; but see Fig. 9), suggesting a mechanism involving Ca2+ entry via L-type voltage-dependent Ca2+ channels, which were putatively activated by GABA-induced depolarization. Baclofen did not produce detectable changes in either membrane potential or Ca2+c (data not shown), implying either that the function of GABABreceptor/Ca2+ channels might have been compromised during acute cell preparation or that the activation of these receptors nominally contributes to membrane potential or Ca2+c at this stage of cortical neuron development. Relatively modest contributions of GABAB receptor/Ca2+channels to Ca2+c levels were indeed shown in cell cultures of migrating and differentiating cortical neurons after recovery from dissociation (see Behar et al., 1996) (see Fig. 9B).
To test the potency of muscimol at GABAAreceptors, the cells were resuspended in low Cl−-containing saline to maximize detection of Cl−-dependent depolarizing responses. Under these conditions, muscimol depolarized more cells in each subpopulation studied (Fig. 5C1, C2) than GABA (or muscimol) did in the saline-containing normal Cl−o (Fig.5A2), with most cells depolarizing to −15 mV rather than to −45 mV (data not shown). These optimized experimental conditions show that all of the depolarizing responses are Cl− ion dependent and that some cells depolarized by GABA in normal saline likely went undetected with this strategy. Systematic dose–response studies under these optimized conditions showed that ≥10 μm concentrations of muscimol were asymptotic in depolarizing up to 46% of TnTx−A2B5−neural precursor cells and up to 35% of DP-TnTxlo neuronal progenitors, whereas ≤5 μm concentrations were asymptotic in depolarizing the great majority of cells in all other neuronal subpopulations. The EC50 values decreased from micromolar to submicromolar as TnTx labeling intensified in differentiating neurons, whereas Hill coefficients remained relatively constant ranging from 1.4 to 1.8 (Fig. 5C2). The increase in agonist potency may be related to the evolving GABAA receptor subunit compositions and receptor densities.
Electrophysiology of GABAAautoreceptor/Cl− channel activity in CP/SP neurons
The concerted expression of GABAergic-signaling components and the presence of releasable GABA at the level of cell bodies and growth cones of differentiating cortical neurons led us to investigate the effects of endogenous GABA on membrane properties of these cells. We used patch-clamp techniques to optimize the recording of Cl−-dependent currents in acutely cultured CP/SP neurons under unperfused and superfused conditions. Without perfusion, all differentiating neurons (n = 8), which were recorded in the whole-cell mode and clamped at negative potentials, exhibited fluctuating baseline current signals, which were reduced after diffusion of bicuculline into the unperfused bath (Fig.6A1). Spectral analysis showed that the bicuculline-sensitive fluctuating baseline signal could be fitted by two Lorentzian terms, indicating two exponential distributions in the burst-length durations of the randomly activated Cl− channels (Fig.6A3). Continuous superfusion of the recorded neurons with fresh saline rapidly eliminated most of the baseline current signal and associated fluctuations (Fig. 6, compare B1,A1), creating a steady DC level with spontaneous intermittent openings of Cl− channels whose frequency was not sufficient to generate a summating current signal.
After superfusion, application of micromolar GABA typically evoked an inward Cl− current response superimposed with random fluctuations in all recorded neurons, which, after spectral analysis, involved the same pair of exponentially distributed burst-length durations found with the endogenous baseline signal recorded in the absence of superfusion (Fig. 6, compareB2,A3).
All of the continuously superfused CP/SP neurons recorded in a whole-cell mode exhibited a residual level of Cl− channel activity. This activity was rapidly and reversibly eliminated by bicuculline (Fig.7A) and reversed polarity at 0 mV (∼ECl) (data not shown). Quantitative analyses revealed single Cl−channel levels of activity in all superfused neurons (Fig.7B) with the unitary properties of GABA-activated Cl− channels. The residual Cl− channel activity most likely reflected autocrine activation of GABAAautoreceptor/Cl− channels by GABA at the undersurface of the neuron, which was not as accessible to superfusion as the upper surface. The bicuculline sensitivity of both the endogenous baseline macroscopic current signal and the microscopic Cl− channel activity persisting during superfusion, together with the close similarities in the burst-length durations estimated for the summating Cl−channel activity composing the baseline and GABA-activated macroscopic currents, strongly suggests that the baseline signal is dominated by GABA-induced activation of GABAAautoreceptor/Cl− channels, which evolves from a surface-accessible compartment.
Autocrine GABAergic signaling tonically elevates Ca2+c levels
We also investigated the effects of endogenous GABA on potentiometric and Ca2+ signaling in differentiating cortical neurons using a noninvasive optical strategy. We used a dual video microscopic-imaging technique to record simultaneously membrane potential and Ca2+c levels of acutely cultured CP/SP neurons. After imaging, the neurons were immunoidentified with TnTx and A2B5 labeling. The analysis was focused on neurons with the SP-TnTx phenotype because most of them were GABAergic at the beginning of culture, although DP-TnTx neurons increasingly became GABAergic after 24 hr of culture (data not shown). The great majority (>80%; n = 32) of SP-TnTxhi neurons, which were continuously superfused with NPM, exhibited baseline membrane potentials of approximately −50 mV (Fig. 8,top). Bicuculline rapidly and reversibly hyperpolarized these cells from −50 mV to near −80 mV. In addition, bicuculline rapidly and reversibly depressed baseline Ca2+c levels in those SP-TnTxhi neurons that coexpressed significant levels of voltage-dependent Ca2+ entry, which was identified by stepwise depolarization with elevated KCl (Fig. 8, bottom). The time courses in potential and Ca2+c changes were nearly superimposable despite the disparities in the response times of the two dyes, indicating that the two parameters were closely linked. The much slower response time of the potentiometric dye (∼60 sec) compared with that of fura-2 (∼1 sec) suggests that the rate of hyperpolarization induced by bicuculline governed the rate of decrease in Ca2+c level. Putatively less-differentiated CP/SP neurons with the SP-TnTxlo phenotype, which constituted ≤15% of the cultured cells, exhibited relatively low baseline Ca2+c levels (<100 nm) and were insensitive to the hyperpolarizing effects of bicuculline. In addition, these neurons did not respond to stepwise increases in [K+]o despite being depolarized to the same membrane potentials as SP-TnTxhi neurons with bicuculline-sensitive baseline Ca2+c levels (Fig. 8). Interestingly, most SP-TnTxhi neurons that had differentiated in culture for 24 hr were depolarized by 20 mm KCl to approximately the same potential and generated approximately the same baseline Ca2+c level that was recorded in 5 mm K+. Thus, the autocrine GABAergic signaling at GABAAreceptor/Cl− channels dominated the baseline properties of these cells over the 5–20 mm range of [K+]o.
To investigate the possible mechanisms underlying autocrine GABAergic regulation of baseline Ca2+c in SP-TnTxhi neurons, we performed pharmacological experiments targeting the contribution of endogenous GABA synthesis, GABAA and GABAB receptors, intracellular Cl− ion homeostasis, and voltage-dependent L-type Ca2+ channels. In addition, the accessibility of endogenous GABA was tested in the presence of albumin serum proteins (i.e., BSA), which purportedly act as natural carriers for a wide spectrum of signaling molecules in vivo. Superfusion with BSA closely mimicked the depressant effects of bicuculline and picrotoxin on Ca2+c levels both in terms of time course of decrease and recovery and extent (Fig.9A). Both phases could be approximated by monoexponential time courses, which were ∼2 min for the decreasing phase and ∼1 min for recovery. In one representative experiment, Ca2+c levels in 30 SP-TnTxhi neurons averaged 97 ± 4 nm (mean ± SEM) during superfusion before BSA, 52 ± 4 nm after the effect of BSA had asymptoted, 99 ± 6 nm in recovery, 59 ± 5 nm after bicuculline and picrotoxin, and 105 ± 6 nm after another recovery. These results demonstrated the persistence and robustness of autocrine GABAergic signaling at GABAAreceptor/Cl− channels under continuous superfusion in saline. Previously, we reported that BSA stabilized the resting potentials of virtually all dissociated cortical cells and cultured CP/SP neurons near or at the equilibrium potential for K+ ions and lowered Ca2+c levels to ∼100 nm or less (Maric et al., 1998c, 2000b). Although the mechanisms of the effects of BSA are as yet unclear, it may be important physiologically during cortical development.
Superfusion with saclofen, a GABAB receptor antagonist, depressed baseline Ca2+c levels in ∼60% of 32 SP-TnTxhi neurons studied (Fig.9B). However, this decrease in Ca2+c level was relatively modest (19 ± 3 nm;n = 20) compared with the effects of antagonists at GABAA receptor/Cl−channels, which decreased Ca2+c levels by 55 ± 5 nm in the same neurons. Superfusion of these neurons with 3-MPA, which blocks GAD-derived synthesis of GABA, decreased baseline Ca2+clevels to an extent similar to that of bicuculline/picrotoxin, when compared in the same experiment. For example, bicuculline/picrotoxin depressed Ca2+c levels in 37 neurons by 52 ± 4 nm, whereas 3-MPA decreased Ca2+c by 58 ± 3 nm (Fig. 9B). However, the time course of the depressant effect of 3-MPA was delayed rather than immediate and gradual compared with that of either GABA receptor antagonists and, unlike them, not rapidly reversible. Ca2+c levels only partially recovered after 10–20 min of superfusion in saline free of 3-MPA. The depressant effects of 3-MPA on baseline Ca2+c did not interfere with the Ca2+c response evoked by exogenous GABA (Fig. 9B), indicating that its effects did not involve activation either of GABAA receptors by GABA or of the downstream components necessary for elevating Ca2+c. Therefore, the GABAergic contribution to baseline Ca2+c levels requires constitutive synthesis of GABA, which is released to act in an autocrine manner at both GABAA and GABAB receptors.
We also used furosemide, which blocks Na-K-2Cl cotransporter activity, to demonstrate the critical importance of the physiological Cl− gradient in the contribution of GABA to baseline Ca2+c levels. Furosemide decreased Ca2+c levels in all of the 26 SP-TnTxhi neurons studied by 43 ± 5 nm with a delayed and gradual time course (Fig. 9C), similar to that recorded with 3-MPA (Fig.9B). These effects were partially reversible over 5–10 min.
Nitrendipine, which blocks voltage-dependent L-type Ca2+ channels, decreased Ca2+c levels of SP-TnTxhi neurons with a time course similar to that recorded with GABAA receptor antagonists, indicating that baseline Ca2+c levels involved Ca2+o entry via L-type Ca2+ channels, which were opened by the depolarization resulting from the autocrine activation by GABA of GABAA receptor/Cl−channels (Fig. 9D). In 27 neurons studied, nitrendipine decreased their baseline Ca2+c by 57 ± 5 nm and blocked evokable Ca2+ entry mediated by K+-induced depolarization.
In a parallel series of experiments, we investigated the possible contribution of ionotropic glutamate receptors and voltage-dependent Na+ channels to tonic Ca2+c signaling of SP-TnTxhi neurons, because these forms of excitability are increasingly expressed in differentiating cortical neurons (Maric et al., 2000b). Superfusion with CNQX and APV, respective antagonists at the AMPA/kainate and NMDA receptors, and TTX, a blocker of voltage-sensitive Na+ action potentials, did not affect baseline Ca2+c levels of the 26 neurons recorded in NPM, whereas all exhibited sensitivity to bicuculline and picrotoxin (data not shown). Taken together, these results indicated that GABAergic signaling via GABAAautoreceptor/Cl− channels dominates the baseline properties of differentiating embryonic cortical neurons independently of the other expressed forms of membrane excitability.
Autocrine GABAergic signaling is critical to neurite outgrowth
The emergence of functional GABAergic-signaling components among differentiating CP/SP neurons and their capacity to release GABA from both cell body and growth cone compartments suggested that some form(s) of GABAergic signaling may occur during neurite outgrowth. We therefore investigated the possible physiological roles of GABAergic signaling during the earliest stages of neuronal process formation and regeneration. CP/SP neurons were cultured for 2–9 d in Neurobasal/B27 medium, which permitted optimal neurite outgrowth and recovery from dissociation. Over the first 48 hr, the majority of neurons developed well differentiated processes (Fig.10A1), with an average total neurite length of 36 ± 3 μm (mean ± SEM;n = 30), and exhibited abundant GABA immunoreactivity (Fig. 10A2). Addition of 3-MPA to block GABA synthesis at the beginning of culture produced approximately a 70% reduction in neurite outgrowth (Fig. 10B1), resulting in an average neurite length of 12 ± 1 μm (mean ± SEM;n = 25) and a threefold reduction of GABA immunoreactivity (Fig. 10B2). This effect was not caused by cytotoxicity, because comparable numbers of neurons survived in 3-MPA-treated preparations as did in control cultures (data not shown).
During initial neurite outgrowth over the first 24–48 hr, Ca2+c levels quantified in neurons under control conditions and in cultures treated with 3-MPA revealed steady baselines of 126 ± 9 nm(n = 30) and 45 ± 3 nm(n = 31), respectively. Bicuculline and picrotoxin decreased Ca2+c by 56 ± 6 nm in these neurons under control conditions but only by 3 ± 3 nm in 3-MPA-treated neurons. Together, these results indicate that 3-MPA effectively attenuated synthesis of GABA by GAD, thus reducing levels of immunodetectable GABA in most neurons. These effects of 3-MPA practically eliminated the indirect contribution to baseline Ca2+c levels. A reduced complement of L-type Ca2+ channels persisted in the neurons exposed to 3-MPA, as manifested by a nearly twofold increase in Ca2+c(to 81 ± 4 nm) after exposure to 50 mm KCl, which is markedly less than the peak Ca2+c response to 50 mm KCl in CP/SP neurons cultured in control conditions. This reduction in peak Ca2+c response to KCl may reflect the marked attenuation in neurite outgrowth and membrane surface area where functional L-type Ca2+channels could have become incorporated.
By 9 d in culture, neurite formation was primarily completed (Fig.10C1), and the number of GABAergic neurons markedly decreased (Fig. 10C2). Furthermore, the facilitating effect of GAD-derived GABA on process formation became nominal, because the remaining GABAergic neurons, which exhibited extensive neurite outgrowth after 9 d in culture, did not show detectable sensitivity to 3-MPA (Fig. 10D1), even after a marked reduction in GABA synthesis (Fig. 10D2). These findings suggest that GAD-derived GABA was not required to maintain neurite outgrowth after outgrowth was completed.
In a parallel set of experiments, we also selectively blocked other components, which we identified in the autocrine GABAergic-signaling circuit, to reveal their possible roles in neurite outgrowth (Fig.11). Mean total neurite length obtained under control conditions after 48 hr of culture in Neurobasal/B27 medium (37 ± 3 μm; n = 31) was effectively reduced with bicuculline (20 ± 2 μm; n = 40), picrotoxin (17 ± 2 μm; n = 43), furosemide (11 ± 1 μm; n = 42), or nitrendipine (12 ± 1 μm; n = 51), although comparable numbers of neurons consistently survived in three independent experiments of each condition as did in the control (data not shown). Furosemide and nitrendipine closely mimicked the effects of 3-MPA in reducing total neurite outgrowth by ∼70% (Fig. 11E,F), whereas bicuculline and picrotoxin were slightly less effective, attenuating total neurite outgrowth by ∼50% (Fig.11B,C).
The possible contribution of GABABreceptor-coupled functions to neurite outgrowth was investigated by incubating CP/SP neurons in saclofen, which modestly decreased baseline Ca2+c levels (Fig.9B). Saclofen had no significant effects on neurite outgrowth (36 ± 3 μm; n = 68) compared with that of control (Fig. 11A,D). Furthermore, exposure to CNQX, APV, atropine, suramin, and/or TTX did not alter baseline Cac2+ levels of CP/SP neurons or affect neurite outgrowth of these cells (data not shown).
Taken together, these pharmacological results implicate GABAA receptor/Cl−channels, Cl− cotransporter activity, and L-type Ca2+ channels in the autocrine GABAergic circuit that facilitates the initial stages of process formation and/or regeneration. However, after 7 d or more in culture when neurite outgrowth had become quite extensive and many neurites made visible contact with each other, pharmacological interruption of the circuit for 24–48 hr had no apparent effects on either Ca2+c levels or morphology (data not shown, but the results resembled those in Fig.10C1,D1). In addition, GABA immunoreactivity gradually disappeared from most neurons over 7 d, beginning at the cell body and then continuing at the process level and ending at the terminals (data not shown, but see Fig. 10C2). Thus, the autocrine GABAergic signaling decreased progressively as CP/SP neurons differentiated extensive neurites.
Neurite outgrowth can be preserved in the absence of GABAergic signaling by activating L-type Ca2+ channels
We interrupted autocrine GABAergic signaling at GABAA receptor/Cl−channel activation and then depolarized CP/SP neurons by adding 20 mm KCl to the growth medium, because this approximated the Ca2+c level sustained by autocrine GABAergic signaling after 24–48 hr in culture (see Fig. 8). Neurons exposed to both bicuculline and picrotoxin exhibited the same degree of attenuation in process formation (data not shown) as seen with either alone (Fig. 11B,C). Inclusion of 20 mm KCl in the medium along with bicuculline and picrotoxin preserved process formation and/or regeneration (Fig.11H), with the mean neurite length (35 ± 3 μm; n = 40) and cellular morphologies closely approximating those evident in control (Fig. 11A) or in control plus 20 mm KCl (Fig. 11G), in which the mean neurite length amounted to 37 ± 3 μm (n = 31) and 39 ± 3 μm (n = 49), respectively. Degrees of neuritogenesis similar to those seen in control were found when 20 mm KCl was included with either 3-MPA or furosemide (data not shown), but not with nitrendipine, the outcome of which resembled that in Figure11F, presumably because the nitrendipine blocked Ca2+ entry via activated L-type Ca2+ channels (see Fig. 9D). These results indicate that activation of L-type Ca2+ channels is the critical downstream mechanism for promoting neurite outgrowth in CP/SP neurons.
GABAergic signaling during neurite outgrowth does not involve vesicular release
To investigate further the mechanisms of GABA release, we examined the subcellular distribution of GABA in differentiating CP/SP neurons during the period of neurite recovery after dissociation. The cells were cultured for 24 hr and examined for GABA expression using an immunogold reaction followed by silver enhancement and electron microscopy. The results typically revealed nonuniform distributions of GABA in the cytoplasm of the cell bodies and growth cones, with some clustering of the immunoreaction product apparent in subplasmalemmal regions (Fig. 12). There was little evidence of GABA compartmentalization in vesicles. Discrete small vesicular organelles arranged near the surface membrane, which are characteristic of those containing GABA at well developed synapses of fast-transmitting neurons, were noticeably absent. Thus, the autocrine GABAergic-signaling circuit expressed by embryonic CP/SP neurons does not appear to involve vesicular exocytosis. Instead, alternate mechanisms of GABA release, including those that involve GABA transporters, may play a role, and elucidating them will be the goal of future investigations.
DISCUSSION
Salient findings
In this study we investigated the morphogenic role of GABA during neuronal differentiation in the rat embryonic neocortex. GABAergic-signaling components, including the expression of GAD65, GAD67, GABA, GABAA, and GABAB receptor subunits, and GABAergic signals at GABAAreceptor/Cl− channels emerged at the earliest stages of neuronal lineage progression in the VZ/SVZ. After radial migration to the CP/SP, the majority of differentiating neurons exhibited autocrine GABAergic signals, which dominated their baseline membrane potential and indirectly their Ca2+c levels via Ca2+ entry through L-type Ca2+ channels. This autocrine GABAergic circuit was critical to neurite outgrowth, because interruption of its individual components including GABA synthesis, GABAA receptor activation, intracellular Cl− ion homeostasis, or L-type Ca2+ channel activation markedly attenuated neurite outgrowth in most GABAergic neurons. In the absence of the autocrine GABAergic signaling, neuritogenesis of these cells could be preserved by K+o-induced depolarization of their plasma membranes and activation of L-type Ca2+ channels, suggesting that Ca2+ entry is the critical factor in sustaining neurite outgrowth of these cells.
GABAergic signaling at GABAA autoreceptors emerges among most postmitotic cortical neurons during neurogenesis and dominates their membrane potential
We have shown previously that, during neocortical development, the majority of postmitotic neurons are polarized at negative potentials, primarily according to a K+ ion gradient (Maric et al., 1998c), and that most of these cells express GABAA receptors and depolarize to GABA via Cl−-dependent and bicuculline- and/or picrotoxin-sensitive mechanisms (Maric et al., 2000b). To study these mechanisms pharmacologically, using exogenous applications of GABAA receptor agonists and antagonists, we found it necessary to supplement all recording solutions with 1 mg/ml BSA, because it effectively eliminated the contribution of endogenous GABAergic signaling from differentiating neurons and thus stabilized baseline membrane potentials for the duration of the experiments. In this study, however, we have also focused our investigation on the physiological roles of endogenous GABA on neuronal development and have therefore omitted BSA from the recording solutions. As expected, omission of BSA depolarized and elevated Ca2+c levels in many differentiating CP/SP neurons, virtually all of which were GAD+ and GABA+. These effects could be predominantly attenuated by the GABAAreceptor/Cl− channel antagonists bicuculline and picrotoxin, by furosemide, which blocks Cl− ion transport into cells, and by 3-MPA, which blocks GAD activity.
The autocrine GABAergic signaling primarily involved spontaneous, random openings of GABAAreceptor/Cl− channels, whereas the contribution of GABAB receptors was minor. Baseline properties dominated by GABA in embryonic CP/SP neurons gradually disappeared after 7 d in culture consistent with a transient role for autocrine signaling during neurite outgrowth (Maric and Barker, unpublished observations). GABAergic baseline signals involving GABAA receptors have been recorded previously both in cultured embryonic hippocampal neurons (Valeyev et al., 1993, 1998) and in early postnatal hippocampal neurons in slices (Ben-Ari et al., 1989). The slice experiments demonstrated that bicuculline-sensitive GABAergic baselines disappear at the end of the first postnatal week as hyperpolarizing GABAergic transient signals emerge.
Spectral analysis revealed that most Cl− channel openings involved estimated burst-length durations of ∼100 msec, similar to those estimated for GABA-induced Cl− currents in newly adherent embryonic cortical neurons without processes (Serafini et al., 1998). Thus, the same channel properties predominate both before and during neurite outgrowth. The similarities in the kinetics of baseline and GABA-activated channels strongly suggest that (1) GABA rather than other substances mediates the baseline Cl− channel activity and (2) submicromolar to micromolar concentrations in solution mimic the intensity of the autocrine GABAergic signal. Superfusion eliminated the baseline current, demonstrating that it was mediated by GABA equilibrating in a surface-accessible compartment, which is consistent with results in embryonic hippocampal neurons (Valeyev et al., 1993,1998; Vautrin et al., 2000). Channel activity during superfusion most likely reflected autocrine signaling at the neuronal surface apposing the coverslip, which would be less accessible to superfusion and similar to the interstitial space. Hence, low numbers of randomly activated GABAAautoreceptor/Cl− channels were sufficient to dominate resting potentials of most embryonic CP/SP neurons in vitro. We have shown previously that exogenous activation of low numbers (<5) of GABAAreceptor/Cl− channels in intact embryonic hippocampal neurons could exert shifts in their membrane potential by 5–10 mV (Maric et al., 1999b).
GABAA receptor subunit expression patterns change as postmitotic neurons migrate from the VZ/SVZ to the CP/SP region
Our data demonstrated that the potency of muscimol at GABAA receptor/Cl−channels increased during neuronal lineage progression. This increase may be related to the developmentally changing subunit patterns and their intrinsic properties and/or to receptor densities. In this regard, approximately the same percentages of TnTx−A2B5−precursor cells and SP-TnTxlo and DP-TnTxlo neuronal progenitors depolarized as expressed α4, β1, or γ1 subunits, whereas a great majority of both SP-TnTxhi and DP-TnTxhi differentiating neurons depolarized, which was comparable with those that expressed either α3, β3, γ2, or γ3 subunits. Thus, the predominant GABAA receptor subunits, α4, β1, and γ1 in precursors and progenitors or α3, β3, γ2, and γ3 in differentiating neurons, are probably coexpressed and form functional Cl− channels.
The potentiometric results can be compared with an electrophysiological study on GABAA receptor-mediated signaling using whole-cell recording (Owens et al., 1999). The authors found that (1) all of the embryonic cortical cells sampled exhibited functional GABAA receptors and (2) EC50 values for activating macroscopic Cl− currents shifted from ∼5 μm in VZ cells to ∼28 μm in CP neurons, whereas Hill coefficients decreased from ∼2 to ∼1. The authors also reported that isolated VZ cells exhibited few functional GABAA receptor/Cl−channels (<5). Thus, the phenotyped VZ/SVZ subpopulations studied here likely express limited numbers of functional GABAA receptor/Cl−channels. However, these could dominate membrane potential and, indirectly, Ca2+c levels, thereby affecting neuronal progenitor proliferation (LoTurco et al., 1995). The EC50 values measured electrophysiologically among VZ and CP neurons contrast with those found using potentiometry, which shifted from approximately micromolar in VZ/SVZ cells to submicromolar in CP/SP neurons. The Hill coefficient in CP neurons also differed from that determined potentiometrically, which remained ∼2. These differences could be related to the different recording strategies and endpoints and/or to the sample sizes, which are relatively limited in patch-clamp studies. Furthermore, if GABAAreceptor/Cl− channels are regulated by soluble components of signal transduction pathways in the cytoplasm [for review, see Moss and Smart (1996)], then these components could be diluted in whole-cell recordings and thus conceivably alter GABAA receptor affinity. Perforated-patch recordings would show whether this helps to explain the differences in the pharmacological parameters derived from electrical and optical recordings.
GABAergic signaling at GABAAautoreceptor/Cl− channels expressed by CP/SP neurons mediates neurite outgrowth via activation of L-type Ca2+ channels
Block of the autocrine GABAergic-signaling circuit attenuated neurite outgrowth in most, but not all, GABAergic CP/SP neurons. These results are consistent with reports implicating GABAA receptor/Cl−channels in the process formation of neurons cultured from different CNS regions and species (Michler, 1990; Barbin et al., 1993; Bird and Owen, 1998). However, both facilitatory and inhibitory effects of GABA on neurite outgrowth have been reported, depending on cell type and culture conditions. HPLC studies showed that growth cones fractionated from the postnatal rat cortex release endogenous GABA spontaneously before the emergence of synaptic vesicle-related proteins and that this release is increased after superfusion with Ca2+o-free saline and enhanced still further by 25 mm KCl (Taylor et al., 1990). The mechanisms underlying release of endogenous GABA from postnatal growth cones and the regulatory role of extracellular Ca2+ in this process have yet to be elucidated. In our experiments, GABA release from embryonic CP/SP neuronal cell bodies and growth cones was Ca2+ dependent. These results suggest a positive feedback loop in the autocrine circuit with Ca2+-dependent GABA release activating Ca2+ entry via L-type Ca2+ channels and promoting GABA release. The loop most likely involves Ca2+-dependent regulation of GAD activities because constitutive synthesis of GABA was necessary to sustain activity in the autocrine circuit.
GABA release from axonal growth cones of embryonic mouse hypothalamic neurons has also been detected electrically (Gao and van den Pol, 2000), and exogenously applied GABA has been shown to elevate Ca2+c in these growth cones via bicuculline- and furosemide-sensitive mechanisms (Obrietan and van den Pol, 1996). Bicuculline also decreased ambient Ca2+c levels in hypothalamic neurons, which had been cultured for 6 d. This was attributed to blockade of synaptically released GABA acting at GABAA receptors. The results of the present study reveal that the autocrine GABAergic circuit operates during the earliest stages of neurite outgrowth before functional synapses form. The intracellular pathway(s) that couples autocrine GABAergic signaling to neurite outgrowth likely involves Ca2+-dependent activation of (1) protein kinase C with subsequent phosphorylation of GAP-43 and Myristoyl alanine-rich protein kinase C substrate proteins (Fukura et al., 1996) and (2) degradation of spectrin and release of α-actinin by calpain (Ohbayashi et al., 1998), which have both been identified as targets of GABAergic signaling in growth cones fractionated from the embryonic and early postnatal rat cortex. The dynamics regarding the complex interplay among the different components at membrane and cytoplasmic levels during neurite outgrowth and how the circuit is developmentally regulated remain to be elucidated.
Footnotes
We acknowledge Dr. Jung-Hwa Tao-Cheng and Virginia A. Tanner at the National Institute of Neurological Disorders and Stroke Electron Microscopy Facility (National Institutes of Health, Bethesda, MD) for providing their invaluable technical expertise and training in EM immunocytochemistry.
Correspondence should be addressed to Dr. Dragan Maric, Laboratory of Neurophysiology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Building 36, Room 2C-02, Bethesda, MD 20892. E-mail: maricd{at}ninds.nih.gov.